Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
KB Home
KBH
Toll Brothers
TOL
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 19.020
- -0.010-0.05%
Trading Dec 30 12:58 ET
695.68MMarket Cap-9.68P/E (TTM)
19.020High18.240Low33.79KVolume18.700Open19.030Pre Close631.63KTurnover0.23%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.15P/B282.05MFloat Cap16.55052wk Low--Dividend TTM14.83MShs Float29.740Historical High--Div YieldTTM4.10%Amplitude16.550Historical Low18.693Avg Price1Lot Size
About Rapport Therapeutics Company
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Company Profile
SymbolRAPP
Company NameRapport Therapeutics
Listing DateJun 7, 2024
Issue Price17.00
Founded2022
CEOMr. Abraham N. Ceesay, M.B.A.
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address1325 Boylston Street,Suite 401
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-321-8020
Websitehttp://www.rapportrx.com
Company Executives
- Name
- Position
- Salary
- Abraham N. Ceesay, M.B.A.
- Chief Executive Officer and Director
- 2.42M
- David Bredt, M.D.,PhD
- Chief Scientific Officer and Director
- --
- Dr. Bradley S. Galer, M.D.
- Chief Medical Officer
- --
- Kathy Wilkinson
- Chief People Officer
- --
- Cheryl Gault
- Chief Operating Officer
- 1.78M
- Troy A. Ignelzi
- Chief Financial Officer
- 2.13M
- Dr. Swamy Yeleswaram, PhD
- Chief Development Officer
- --
- Dr. Steven M. Paul, M.D.
- Chairman of the Board
- 568.99K
- Dr. James I. Healy, M.D.,PhD
- Director
- --
- Raymond Kelleher, M.D.,PhD
- Director
- --
- Dr. Reid M. Huber, PhD
- Director
- 400.26K
- Terry-Ann Burrell, M.B.A.
- Director
- --
- Dr. John M. Maraganore,PhD
- Director
- --
- Dr. Jeffrey K. Tong, PhD
- Director
- 55.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.